TARGETING GROWTH TO CURE CANCER
Let’s work together to revolutionize oncology therapeutics
BIMINI Biotech is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing. We do this through an unique mode-of-action.
BIMINI Biotech is always open for collaborations to accelerate drug development. Please do not hesitate to contact us.